impact factor, citescore
logo
 

Full Papers

 

Epidemiology and clinical domains of Behçet’s disease in the Cantabria region, Northern Spain.


1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11

 

  1. Department of Ophthalmology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  2. Department of Ophthalmology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  3. Department of Ophthalmology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  4. Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  5. Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  6. Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  7. Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  8. Department of Rheumatology, Hospital Sierrallana, IDIVAL, Torrelavega, Spain.
  9. Department of Rheumatology, Hospital Universitario de La Princesa, Madrid; Cátedra UAM-Roche, EPID-Future, Universidad Autónoma de Madrid (UAM), Madrid, Spain.
  10. Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  11. Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain. rblancovela@gmail.com

CER15693
2023 Vol.41, N°10
PI 1991, PF 1997
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 37083163 [PubMed]

Received: 20/03/2022
Accepted : 30/11/2022
In Press: 21/04/2023
Published: 30/10/2023

Abstract

OBJECTIVES:
The prevalence of Behçet’s disease (BD) has a considerable geographical and temporal variability. Data regarding epidemiology in Spain are limited. Our study aimed to assess the epidemiology and clinical domains of BD in a population-based cohort from Northern Spain and to compare the results with other geographical areas of other countries.
METHODS:
We conducted a cross-sectional study of a well-defined population in Northern Spain. Cases of suspected BD between January 1980 and December 2018 were identified. The diagnosis of BD was established according to the International Study Group (ISG) for Behçet’s Disease. The incidence of BD between 1999 and 2018 was estimated by sex, age, and year of diagnosis.
RESULTS:
Of 120 patients with probable BD, 59 patients met ISG criteria and were finally included in the study, with a male/female ratio of 0.97; mean age 49.7±14.7 years. Incidence during the period of study was 0.492 per 100,000 people, observing an increase from January 1999 to December 2018. Prevalence was 10.14 per 100,000 inhabitants in 2018. Clinical manifestations were relapsing aphthous stomatitis (100%), genital ulcers (78%), skin involvement (84.7%), joint involvement (64.4%), uveitis (55.9%), central nervous system (16.9%), vascular (10.2%), and gastrointestinal manifestations (6.8%).
CONCLUSIONS:
The prevalence of BD in Cantabria is higher than in other Southern European countries. This difference may reflect a combination of geographic, genetic, or methodological variations, as well as the free accessibility to the Spanish Public Health System for the entire population. Clinical phenotypes observed are similar to those described in other world regions.

DOI: https://doi.org/10.55563/clinexprheumatol/z32rhm

Rheumatology Article

Rheumatology Addendum